Biomarkers that are predictive of clinical benefit in Trop-2-expressing triple-negati

[News]

Oncotarget recently published "Predictive biomarkers for sacituzumab govitecan efficacy in Trop-2-expressing triple-negative breast cancer" which reported that the authors investigated whether Trop-2-expression and homologous recombination repair of SN-38-mediated double-strand DNA breaks play a role in the sensitivity of triple-negative breast cancer to SG.

More... (https://www.news-medical.net/news/20201103/Biomarkers-that-are-predictive-of-clinical-benefit-in-Trop-2-expressing-triple-negative-breast-cancer.aspx)